Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Getting to an Improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management (GOULD) a Registry of High Cardiovascular Risk Subjects in the United States

NCT02993120 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT02993120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02993120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Getting to an Improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management (GOULD) a Registry of High Cardiovascular Risk Subjects in the United States
Lead sponsor
Amgen
Phase
Observational
Overall status
Completed
Start date
December 6, 2016
Completion date
August 6, 2021
Enrollment
5,006 (actual)
Sites
118

Conditions

As the registry lists them; a condition with its own page is linked.

ascvd management, dyslipidemia, medical conditions to be studied